BiomarkersResearch
The Community General Practitioner and General Specialist‐based Cognitive Screening to Identify Early Decline in Seniors in Germany Study (COGSCREEN 2)
AAIC 2025 Abstract
Abstract
Background: While knowledge about dementia and its causes is increasing rapidly, healthcare systems remain ill‐equipped to detect cognitive decline in the early stages of neurodegenerative diseases such as Alzheimer's disease (AD).
